Imidazolyl analogs as syk inhibitors
US9487504B2 · kind B2 · utility
1Cited by
23References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 18, 2013 |
| Grant date | Nov 8, 2016 |
| Priority date | — |
| Expiry date | Jun 18, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel imidazole analogs of Formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.